Publisher： Bentham Science Publishers
E-ISSN： 1873-5576|9|3|419-438
ISSN： 1568-0096
Source： Current Cancer Drug Targets, Vol.9, Iss.3, 2009-05, pp. : 419-438
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ixabepilone delivers in ER− and HER2+ breast cancer
Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. :
Access to resources
Recommend
Lapatinib no help in HER-2-negative breast cancer
Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. :
Trastuzumab tallies up in HER2+ breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. :
Trastuzumab tallies up in HER2+ breast cancer
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :
Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
By Taskar Kunal Rudraraju Vinay Mittapalli Rajendar Samala Ramakrishna Thorsheim Helen Lockman Julie Gril Brunilde Hua Emily Palmieri Diane Polli Joseph Castellino Stephen Rubin Stephen Lockman Paul Steeg Patricia Smith Quentin
Pharmaceutical Research, Vol. 29, Iss. 3, 2012-03 ,pp. :